As a seasoned program and portfolio management consultant with executive-level experience in the biopharmaceutical industry, I guide organizations in therapeutic areas such as Oncology, Immunology, CNS, and Autoimmune Diseases. I collaborate with leadership teams to develop drug strategies from early research to commercialization, ensuring alignment with corporate goals. By focusing on building effective governance structures and nurturing high-performing teams, I help streamline decision-making and optimize project portfolios for meaningful impact. My approach prioritizes collaboration and innovation, managing complex programs to deliver transformative therapies.

- Led the Program Management department, overseeing the strategy, integration, and execution of Research, Development, Manufacturing, Commercial, Business Development, and Governance activities.- Directed R&D Operations, steering due diligence, asset transfer, new subsidiary design and stand up, strategic integrated development planning, and execution of the development plan.- Served as Chief of Staff to Head of R&D, facilitating communication and alignment among department heads and key stakeholders.- Introduced organizational infrastructure through various operational initiatives and PM best practices, improving efficiency, consistency, scalability, and morale.- Modernized program dashboards and reporting tools, enhancing alignment and awareness.- Managed various business processes, including budgeting, forecasting, contracting, and resource planning.- Acted as Program Manager for multiple development programs, spanning oncology, inflammation and immunology, and lung disease, including therapeutics, diagnostics, and devices.

- Restructured and re-scoped the PM function, emphasizing leadership and overarching accountability.- Established a robust R&D governance structure, transforming the process for decision-making and project review. Standardized programmatic decision-making methodology, team structures, roles and responsibilities, communication tactics, and record-keeping across the organization.- Co-chaired the R&D Portfolio Committee, governing major programmatic decisions and portfolio reviews.- Partnered with Finance to drive annual and 5-year budget preparation, review, and approval.- Worked with peers to identify, develop, and implement initiatives to enhance efficiency, scalability, retention, resource planning, talent review, and commitment to Diversity, Equity, and Inclusion (DEI).- Launched modernized reporting tools to improve communication, track progress, and ensure alignment.- Spearheaded the Development COVID Task Force, ensuring rapid decision-making during the pandemic.- Led the SOP Committee, responsible for strategic planning, compliance, and oversight of R&D SOPs.- Sought advisor and coach, helping navigate complex tactical and interpersonal situations.

- Program Lead (“PL”), Program Manager, and Business Development Lead for Nektar’s most advanced R&D program, NKTR-181, a novel mu-opioid agonist for the treatment of moderate-to-severe chronic pain. Steered cross-functional strategic planning and execution, leading to positive Phase 3 clinical trials results and Nektar’s first NDA filing.- Directed a cross-functional team of over 75 people, chiefly accountable for strategizing, planning, tracking, coordinating, and executing an integrated timeline of activities (Clinical, CMC, Nonclinical, Regulatory, Commercial, Legal, Finance). Led team through 20+ clinical trials (Phase 1/2/3), 12 FDA meetings, numerous publications and poster presentations, efficient and reliable budgeting, and compliant navigation of complex DEA regulations for controlled substances.- Drove strategy and execution for New Drug Application (NDA) Filing comprised of approximately 3,500 files / 2 million pages. Achieved submission within 6 months of project kickoff, 3 months ahead of target.

- Program Manager leading cross-functional teams for lead R&D program, with oversight and accountability for all projects and phases of preclinical and clinical development and commercialization.- Developed and implemented a program management plan that provided visibility into all aspects of the project, including budget, scope, timeline, risks, and resources.- Coordinated efforts and led preparation for several health authority meetings to receive input and obtain concurrence regarding the proposed development plan and NDA submission strategy.- Worked closely with Finance to ensure accurate near-term and 5-year budget planning modules.

- Responsible for directing projects, maximizing resources, coordinating decision-making processes, facilitating information flow, and ensuring completion of projects on schedule and within budget.- Created and successfully led the Medical Writing Subteam to relieve Clinical Study Report (CSR) backlog and the Publication Subteam to push scientific discoveries and clinical findings into the public domain.

- Directed negotiations with the support of legal, IP, and other key participants to generate new business.- Alliance Management Lead for various strategic business partnerships.- Successfully negotiated various Supply Agreements with strategic development partners.- Supported due diligence preparation for potential partnerships, alliances, acquisitions, and joint ventures.- Managed relationship with Contract Research Organization (CRO) for lead R&D program.

- Originated and led bi-annual “Strategic Alliances & Manufacturing” portfolio reviews.- Analyzed industry trends and identified strategic opportunities for the business.- Conducted comparable deal analysis and NPV modeling for partnership/acquisition purposes. Maintained active “Comparable Deals” database.- Assisted Investor Relations department with building all corporate presentations.

- Executed Chapter 11 Corporate Restructuring process for significant clients including Blockbuster, Charter Communications, Circuit City, Washington Mutual, Hartmarx, Lear, Pilgrim’s Pride, Sega, and Visteon.- Designed and generated complex reports for clients, legal team, financial advisors, and court staff - methods and outputs adopted as new company standards for all cases.- Led and executed large-scale mailings, including drafting and filing of relevant court documents.- Directed a team of 25 Project Specialists to track and analyze reclamation demands.